Efficient screening method of the thiopurine methyltransferase polymorphisms for patients considering taking thiopurine drugs in a Chinese Han population in Henan Province (central China)

Clinica Chimica Acta

Volumn 376, Issue 1-2, 2007, Pages 45-51

  Zhang, Li Rong ^a   Song, Dong Kui ^b   Zhang, Wei ^b   Zhao, Jun ^a   Jia, Lin jing ^a   Xing, Dong Liang ^b  

^a ZHENGZHOU UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Genetic polymorphism; HPLC; Phenotyping; Thiopurine S methyltransferase

Indexed keywords

ERYTHROCYTE ENZYME; THIOPURINE METHYLTRANSFERASE;

ADULT; ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME POLYMORPHISM; ERYTHROCYTE; FEMALE; GENE MUTATION; GENOTYPE; HEMODIALYSIS; HETEROZYGOTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOZYGOTE; HUMAN; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING; UREMIA;

6-MERCAPTOPURINE; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; GENE FREQUENCY; GENETIC SCREENING; GENOTYPE; HUMANS; MALE; METABOLIC DETOXICATION, DRUG; METHYLTRANSFERASES; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; RENAL DIALYSIS; UREMIA;

EID: 33845346810     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.07.010     Document Type: Article

References (32)

1. Weinshilboum R.M., Otterness D.M., and Szumlanski C.L. Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol 39 (1999) 19-52
2. McLeod H.L., Krynetski E.Y., Relling M.V., and Evans W.E. Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia 14 (2000) 567-572
3. Weinshilboum R.M., and Sladek S.L. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 32 (1980) 651-662
4. McLeod H.L., Lin J.S., Scott E.P., Pui C.H., and Evans W.E. Thiopurine methyltransferase activity in American white subjects and black subjects. Clin Pharmacol Ther 55 (1994) 15-20
5. Krynetski E.Y., and Evans W.E. Genetic polymorphism of thiopurine S-methyltransferase: molecular mechanisms and clinical importance. Pharmacology 61 (2000) 136-146
6. Dubinsky M.C., Yang H., Hassard P.V., et al. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatorybowel disease. Gastroenterology 122 (2002) 904-915
7. McLeod H.L., and Siva C. The thiopurine S-methyltransferase gene locus- implications for clinical pharmacogenomics. Pharmacogenomics 3 (2002) 89-98
8. Yates C.R., Krynetski E.Y., Loennechen T., et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 126 (1997) 608-614
9. Krynetski E.Y., and Evans W.E. Genetic polymorphism of thiopurine S-methyltransferase: molecular mechanisms and clinical importance. Pharmacology 61 (2000) 136-146
10. Spire-Vayron de la Moureyre C., Debuysere H., Sabbagh N., et al. Detection of known and new mutations in the thiopurine S-methyltransferase gene by single-strand conformation polymorphism analysis. Hum Mutat 12 (1998) 177-185
11. Schaeffeler E., Lang T., Zanger U.M., Eichelbaum M., and Schwab M. High-throughput genotyping of thiopurine S-methyltransferase by denaturing HPLC. Clin Chem 47 (2001) 548-555
12. Otterness D., Szumlanski C., Lennard L., et al. Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms. Clin Pharmacol Ther 62 (1997) 60-73
13. Schutz E., von Ahsen N., and Oellerich M. Genotyping of eight thiopurine methyltransferase mutations: three-color multiplexing, "two-color/shared" anchor, and fluorescence-quenching hybridization probe assays based on thermodynamic nearest-neighbor probe design. Clin Chem 46 (2000) 1728-1737
14. Weinshilboum R.M., Raymond F.A., and Pazmino P.A. Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties. Clin Chim Acta 85 (1978) 323-333
15. Kroplin T., Weyer N., Gutsche S., and Iven H. Thiopurine S-methyltransferase activity in human erythrocytes: a new HPLC method using 6-thioguanine as substrate. Eur J Clin Pharmacol 54 (1998) 265-271
16. Ganiere-Monteil C., Pineau A., Kergueris M.F., Azoulay C., and Bourin M. Thiopurine methyl transferase activity: new extraction conditions for high-performance liquid chromatographic assay. J Chromatogr B Biomed Sci Appl 727 (1999) 235-239
17. Anglicheau D., Sanquer S., Loriot M.A., Beauneand P., and Therve E. Thiopurine methyltransferase activity: new conditions for reversed-phase high-performance liquid chromatographic assay without extraction and genotypic-phenotypic correlation. J Chromatogr B Analyt Technol Biomed Life Sci 773 (2002) 119-127
18. Chocair P.R., Duley J.A., Simmonds H.A., and Cameron J.S. The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients. Transplantation 53 (1992) 1051-1056
19. Pazmino P.A., Sladek S.L., and Weinshilboum R.M. Thiol S-methylation in uremia: erythrocyte enzyme activities and plasma inhibitors. Clin Pharmacol Ther 28 (1980) 356-367
20. Blin N., and Stafford D.W. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 3 (1976) 2303-2308
21. Collie-Duguid E.S., Prichard S.C., Powrie R.H., et al. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics 9 (1999) 37-42
22. Zhang J.P., Guan Y.Y., Wu J.H., Xu A.L., Zhou S., and Huang M. Phenotyping and genotyping study of thiopurine S-methyltransferase in healthy Chinese children: a comparison of Han and Yao ethnic groups. Br J Clin Pharmacol 58 (2004) 163-168
23. Spire-Vayron de la Moureyre C., Debuysere H., Fazio F., et al. Characterization of a variable number tandem repeat region in the thiopurine S-methyltransferase gene promoter. Pharmacogenetics 9 (1999) 189-198
24. Schwab M., Schaffeler E., Marx C., et al. Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism. Pharmacogenetics 12 (2002) 429-436
25. Hon Y.Y., Fessing M.Y., Pui C.H., Relling M.V., Krynetski E.Y., and Evans W.E. Polymorphism of the thiopurine S-methyltransferase gene in African-Americans. Hum Mol Genet 8 (1999) 371-376
26. Spire-Vayron de la Moureyre C., Debuysere H., Mastain B., et al. Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population. Br J Pharmacol 125 (1998) 879-887
27. Loennechen T., Utsi E., Hartz I., Lysaa R., Kildalsen H., and Aarbakke J. Detection of one single mutation predicts thiopurine S-methyltransferase activity in a population of Saami in northern Norway. Clin Pharmacol Ther 70 (2001) 183-188
28. Rossi A.M., Bianchi M., Guarnieri C., Barale R., and Pacifici G.M. Genotype-phenotype correlation for thiopurine S-methyltransferase in healthy Italian subjects. Eur J Clin Pharmacol 57 (2001) 51-54
29. Reis M., Santoro A., and Suarez-Kurtz G. Thiopurine methyltransferase phenotypes and genotypes in Brazilians. Pharmacogenetics 13 (2003) 371-373
30. Indjova D., Atanasova S., Shipkova M., Armstrong V.W., Oellerich M., and Svinarov D. Phenotypic and genotypic analysis of thiopurine S-methyltransferase polymorphism in the Bulgarian population. Ther Drug Monit 25 (2003) 631-636
31. McLeod H.L., Krynetski E.Y., Wilimas J.A., and Evans W.E. Higher activity of polymorphic thiopurine S-methyltransferase in erythrocytes from neonates compared to adults. Pharmacogenetics 5 (1995) 281-286
32. Lysaa R.A., Giverhaug T., Wold H.L., and Aarbakke J. Inhibition of human thiopurine methyltransferase by furosemide, bendroflumethiazide and trichlormethiazide. Eur J Clin Pharmacol 49 (1996) 393-396